Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial

BACKGROUND: Praziquantel has been the drug of choice for schistosomiasis control for more than 40 years, yet surprisingly, the optimal dose for children younger than 4 years is not known. We aimed to assess the efficacy and safety of escalating praziquantel dosages in preschool-aged children (PSAC)....

Descripción completa

Detalles Bibliográficos
Autores principales: Coulibaly, Jean T, Panic, Gordana, Silué, Kigbafori D, Kovač, Jana, Hattendorf, Jan, Keiser, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471607/
https://www.ncbi.nlm.nih.gov/pubmed/28619227
http://dx.doi.org/10.1016/S2214-109X(17)30187-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471607/
https://www.ncbi.nlm.nih.gov/pubmed/28619227
http://dx.doi.org/10.1016/S2214-109X(17)30187-0

Ejemplares similares